Cargando…
Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
OBJECTIVE: Obesity is associated with a state of chronic low-grade inflammation mediated by immune cells that are primarily located to adipose tissue and liver. The chronic inflammatory response appears to underlie obesity-induced metabolic deterioration including insulin resistance and type 2 diabe...
Autores principales: | Kiefer, Florian W., Zeyda, Maximilian, Gollinger, Karina, Pfau, Birgit, Neuhofer, Angelika, Weichhart, Thomas, Säemann, Marcus D., Geyeregger, René, Schlederer, Michaela, Kenner, Lukas, Stulnig, Thomas M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844841/ https://www.ncbi.nlm.nih.gov/pubmed/20107108 http://dx.doi.org/10.2337/db09-0404 |
Ejemplares similares
-
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
por: Kiefer, F. W., et al.
Publicado: (2011) -
Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage
por: Jürets, Alexander, et al.
Publicado: (2016) -
Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity
por: Tardelli, Matteo, et al.
Publicado: (2016) -
An accelerated mouse model for atherosclerosis and adipose tissue inflammation
por: Neuhofer, Angelika, et al.
Publicado: (2014) -
Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma
por: Nardo, Alexander D., et al.
Publicado: (2020)